The AIDD-CTP is led by Exscientia, in partnership with Queen Mary, Nxera Pharma, and MSD. These form the core partners in the programme, and jointly oversee the development of the programme, ensuring the successful delivery of relevant, and high-calibre PhD training.
Since the programme started, the AIDD-CTP has welcomed involvement from additional industry partners who have joined the programme to co-sponsor studentships. The programme is open to wide engagement from industry partnerships to enrich the training environment, and potential partners interested in exploring opportunities for engagement in the programme can contact us on deri@qmul.ac.uk.
Exscientia is a technology-driven drug design and development company, committed to creating more effective medicines for patients, faster. Exscientia combines precision design with integrated experimentation, aiming to invent and develop the best possible drugs in the most efficient manner.
Nxera Pharma's mission is to accelerate the development of life-changing medicines by investing in science and technology
Transforming the lives of millions of patients in the UK by providing innovative medicines, vaccines, and services through partnership with the NHS.